The provided HTML content discusses the revision of CGHS (Central Government Health Scheme) rates in India. This topic is primarily administrative and financial within the healthcare sector, focusing on reimbursement policies rather than specific medical procedures or specialties.
Upon reviewing the provided list of OC Academy courses, there isn’t a direct match for a course focused on healthcare administration, policy, or reimbursement schemes. The closest connections are to general medical specialities that would be affected by such rate revisions.
Given the content’s focus on healthcare costs, reimbursements, and various medical procedures (bypass graft surgery, pacemaker implantation, cancer surgeries), the most relevant general course category would be related to the overall practice of medicine or specific high-cost treatment areas.
Therefore, I will link to the “Certification Course In General Practice” as it represents a broad area of medical practice that would be impacted by these reimbursement changes. While not a perfect fit, it’s the most logical connection to a general medical course available.
Here’s the modified HTML:
The Ministry of Health and Family Welfare (MoHFW) has recently announced a significant CGHS rates revision, impacting healthcare expense reimbursements for millions of central government employees and pensioners. This comprehensive update, which will take effect from October 13, 2025, aims to rationalize the costs of various medical services availed through the Central Government Health Scheme (CGHS) empanelled healthcare organizations.
Dr. Satheesh Y. H., Director of CGHS, issued an office memorandum confirming these changes. The revised rates are structured to ensure fairness and sustainability across the healthcare ecosystem.
Rationalizing CGHS Reimbursement Rates
A key aspect of this CGHS rates revision is the rationalization of healthcare service charges. This new framework considers several factors, including the accreditation status of the hospital, its classification, the city category (Tier I, II, or III), and the beneficiary’s ward entitlement. Significantly, super specialty hospitals, defined as facilities with over 200 beds offering advanced services, can now charge 15 percent more than NABH-accredited hospitals for identical procedures within the same city category.
For example, the cost for a bypass graft surgery at a super specialty facility has been set at Rs 2,07,000. In comparison, NABH-accredited hospitals can charge up to Rs 1,80,000, while non-NABH facilities are limited to Rs 1,53,000. Additionally, for the implantation of a permanent pacemaker, super specialty facilities may charge Rs 40,480. Similarly, NABH-accredited and non-NABH hospitals have rates fixed at Rs 35,200 and Rs 29,920, respectively. However, it is important to note that cancer surgeries have been explicitly excluded from this revision, and their rates will continue under existing CGHS rules.
Moreover, certain services, including consultations, radiotherapy, investigations, day care procedures, and minor procedures that do not require hospital admission, will maintain uniform rates irrespective of the beneficiary’s ward entitlement. This measure helps ensure equitable access to essential basic services.
Industry Welcomes CGHS Rates Revision
The healthcare industry has broadly welcomed the MoHFW’s decision. Ameera Shah, President of NATHEALTH, an apex body representing the Indian healthcare sector, expressed optimism about the changes. She emphasized that CGHS is a vital program for millions of beneficiaries. Shah stated that the revised rates will undoubtedly improve access to safe and effective healthcare while simultaneously enhancing the overall efficiency of the system.
Private healthcare providers have long advocated for a revision of CGHS rates. They previously cited that the outdated rates were financially unsustainable for their operations, often leading to payment delays and, consequently, patients being forced to settle bills directly. This revision is seen as a crucial step towards addressing these long-standing issues and fostering a more sustainable operating environment for hospitals. Furthermore, Shah suggested that CGHS and other government-sponsored schemes should be periodically benchmarked to the Consumer Price Index (CPI). This would ensure predictability, sustainability, and a win-win value proposition for patients, providers, and policymakers alike.
Frequently Asked Questions
Q1: What is the effective date for the revised CGHS rates?
A: The revised CGHS rates will be effective from October 13, 2025.
Q2: What factors determine the new CGHS reimbursement rates?
A: The revised rates are rationalized based on the hospital’s accreditation status (e.g., NABH), hospital type (e.g., super specialty), city classification, and the beneficiary’s ward entitlement.
Q3: Are all medical procedures covered under the new CGHS rate revision?
A: Most healthcare services will see revised rates, but cancer surgeries have been specifically excluded from this revision and will continue to operate under existing CGHS rules and rates.
References
- Centre revises government employees’ health scheme reimbursement rates – ETHealthworld
- CGHS Rule 2025: New Rates & Policy Changes Explained – Dental Park
- Union Health Ministry Revises CGHS Package Rates for the benefit of CGHS Beneficiaries – PIB
- Health Ministry decides to revise CGHS package rates, simplifies referral process
- Central govt employees, pensioners: Rates of CGHS packages revised; full list of CGHS treatments, new rates, eligibility – The Economic Times
- After DA hike, biggest CGHS rate revision in 15 years for central govt employees — details here – The Financial Express
- CGHS circular dated 3/10/25 CGHS REVISED RATES – YouTube
- Health industry bodies welcome CGHS’ move to revise rates after 15 years – greaterkashmir
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.